dRx Capital
Overview
dRx Capital is a venture capital fund, backed by Novartis and Qualcomm, that invests in digital health, pharmaceutical technology, and healthcare artificial intelligence.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Meekono | Nov 2021 | Series A | Co-investor |
| NuvoAir | Jun 2021 | Series A | Co-investor |
| Octave Bioscience | Jul 2023 | Series B Extension | Co-investor |
| Flywheel | Nov 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is dRx Capital based?
dRx Capital is headquartered in Basel, Switzerland.
When was dRx Capital founded?
dRx Capital was founded in 2015.
How many portfolio companies does dRx Capital have?
dRx Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in dRx Capital's portfolio?
Portfolio companies visible on Caplight include Meekono, NuvoAir, Octave Bioscience, Flywheel.
What was dRx Capital's most recent investment shown here?
dRx Capital's most recent investment in this portfolio sample was in Octave Bioscience in 2023.
What sectors does dRx Capital focus on?
dRx Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does dRx Capital focus on?
dRx Capital typically invests at the Mid stage.
What is dRx Capital's AUM?
dRx Capital's assets under management are estimated between $100.0M and $100.0M.